Research
Metabolic adaptation
Weight-reducing anti-diabetic agents and anti-obesity medications can effectively address both obesity and type 2 diabetes mellitus (T2DM).
Practitioners should consider using these combined strategies for better management of patients with obesity and T2DM.
StrongSupportsmedium confidence
Novel weight-reducing anti-diabetic agents along with anti-obesity medications (AOMs) can help medical providers address both conditions simultaneously and effectively.
Why this rating
The abstract summarizes a review of multiple studies.
Source
Combined medical strategies for the management of type 2 diabetes mellitus and obesity in adults
Mohamad Sirri Tarazi et al. · Expert Opinion on Pharmacotherapy · 2021
DOI 10.1080/14656566.2021.1942841
reviewCited 3×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Utilizing a combination of weight-reducing anti-diabetic agents, anti-obesity medications, and surgical procedures can lead to better clinical outcomes in patients with obesity and T2DM.Strong
- Emerging pharmacologic agents like tirzepatide and bimagrumab show promise in changing standards of care for cardiometabolic disease management.Strong
Related findings · Metabolic adaptation
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →